A robot operating with a popular Internet-based artificial intelligence system consistently gravitates to men over women, white people over people of color, and jumps to conclusions about peoples’ jobs after a glance at their face, a study led by Johns Hopkins University, Georgia Institute of Technology, and University of Washington researchers finds.

An AI tool was assessed by researchers to predict cancer risk in lung nodules. The study was led by the Perelman School of Medicine, University of Pennsylvania and the model seems to work equally well on diagnostic CT and low-dose screening CT.

Reef health can be measured with the help of sound recordings. Scientists at the University of Exeter conducted a study in which a computer algorithm was trained to identify healthy and degraded reefs based on numerous recordings. The result showed that the computer successfully identified reef health 92 % of the time.

A new technique developed by the National Center for Atmospheric Research (NCAR) uses artificial intelligence to efficiently update the vegetation maps that are relied on by wildfire computer models to accurately predict fire behavior and spread.

Sanofi and Google announced that they plan to establish a new virtual Innovation Lab. The partners aim to radically transform how future medicines and health services are delivered by tapping into the power of emerging data technologies.

University of Minnesota Twin Cities researchers have developed a more accurate, less invasive technology that allows amputees to move a robotic arm using their brain signals instead of their muscles.

Intelligent Metasurfaces refreshed human insights into many fundamental laws. They have unlocked many novel devices and systems, like cloaking, tunneling, and holograms. What else do they hold in store?

Following recent clinical trial, biotech firm Enbiosis announces a breakthrough in the treatment of irritable bowel syndrome, which affects one in every ten people.

A new research project aims to improve treatment for patients with prostate, breast and lung cancer through artificial intelligence. The consortium behind the project wants to develop healthcare evidence-generation practices for the incorporation of real-world evidence into clinical practice guidelines (CPGs).

Samsung Biologics and Enzolytics announced the signing of a strategic CDMO partnership agreement for the development and manufacturing of Anti-HIV and Anti-SARS-CoV-2 Monoclonal Antibody Therapies.